Article Text


P10.16 Factors associated with acceptance of genital herpes testing for black patients presenting for care at an std clinic
  1. L Elopre,
  2. N Van Wagoner,
  3. B Van Der Pol,
  4. M Whitfield,
  5. E Hook
  1. Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham AL


Background 15.5% of the population in the United States is infected with herpes simplex virus-type 2 (HSV-2). HSV-2 rates are disproportionately high in black Americans, with seroprevalence approaching 50% in some communities. Knowledge of infection status is an important prevention tool. We evaluated barriers to acceptance of serological testing for HSV-2 in black patients presenting to an STD clinic.

Methods This ongoing study evaluates factors associated with HSV-2 serological test acceptance in patients living in the Southeastern US Participants did not report a history of genital herpes and data analyses were restricted to black patients (93.5% of the study population). Sera were tested with HerpeSelect® assays. χ2 tests determined differences between groups based on testing. Univariate (UV) and multivariable (MV) analyses were performed to determine odds ratios (OR) for factors associated with test acceptance.

Results Of 112 participants, only 85 (75.9%) accepted HSV-2 testing. Although only one participant felt their test results would be positive, seroprevalence for HSV-2 was 31.7%. Test acceptance was more common in persons presenting for symptom evaluation (53.1%) than as contacts (17.2%) or for screening (29.7%). In UV analyses, participants who reported depression (OR 2.8; 95% CI 1.1, 8.3), previous HIV testing (OR 3.0; 95% CI 1.1, 7.9) and STI history (OR 5.8; 95% CI 1.5, 24.4) were more likely to accept testing. Only previous HIV testing (AOR 7.4; 95% CI 1.2, 66.4) remained significant in MV analysis.

Conclusions While many participants accepted testing, the rate was lower than in previous studies with little perception of risk. Culturally tailored interventions are needed to enhance assessment of HSV risk and test acceptance.

Disclosure of interest statement No disclosures.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.